[Federal Register Volume 62, Number 230 (Monday, December 1, 1997)]
[Notices]
[Page 63550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-31321]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Office of Public Health and Science; Notice of Meeting of the 
Advisory Committee on Blood Safety and Availability

agency: Office of Public Health and Science.

action: Notice of meeting.

-----------------------------------------------------------------------

    The Advisory Committee on Blood Safety and Availability will meet 
on January 29, 1998 from 8:00 AM to 4:30 PM and on January 30, 1998 
from 8:00 AM to 3:30 PM. The meetings will take place in Room 800, 
Hubert H. Humphrey Building, 200 Independence Ave., S.W., Washington, 
DC 20201. The meeting will be entirely open to the public.
    The Committee will consider the theoretical possibility that 
Creutzfeldt-Jakob disease (CJD) can be transmitted by blood 
transfusion. On January 29, 1998 the Committee will review information 
previously presented to it on April 25, 1997 and receive reports of 
scientific and clinical advances since then. The Committee will then 
receive a presentation of current and pending regulatory activities 
relevant to the theoretical possibility of CJD transmission, and hear 
invited comments from consumers and industry. At the conclusion of 
these presentations, the public will be invited to comment. On January 
30, 1998 the Committee will consider what if any recommendations it 
would make to the Department on this matter.
    Prospective speakers should notify the Executive Secretary of their 
desire to address the Committee and should plan for no more than 5 
minutes of comment.

contact: Stephen D. Nightingale, MD, Executive Secretary, Advisory 
Committee on Blood Safety and Availability, Office of Public Health and 
Science, Department of Health and Human Services, Hubert H. Humphrey 
Building, 200 Independence Avenue S.W., Washington, DC 20201. Phone 
(202) 690-5560 FAX (202) 690-7560 e-mail [email protected].

    Dated: November 21, 1997.
Stephen D. Nightingale,
Executive Secretary, Advisory Committee on Blood Safety and 
Availability.
[FR Doc. 97-31321 Filed 11-28-97; 8:45 am]
BILLING CODE 4160-17-M